Skip to content

Assessment of Routine Oral Screening Programs for New Prisoners

Assessment of Routine Oral Screening Programs for New Prisoners in France

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03736070
Acronym
DepiDent
Enrollment
1000
Registered
2018-11-08
Start date
2018-03-01
Completion date
2021-12-01
Last updated
2020-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Disease

Brief summary

In 2018, 10 detention centers in France will start organisational programs to improve the quality of screening of oral diseases, relatively to French recommendations, among new prisoners in France. Our study aims 1) to assess the prevalence and nosology of oral diseases ; 2) to describe the care pathway of participants during their stay in the detention center where they were included ; 3) to assess the cost of care per patient, from a societal perspective, using a top-down method.

Interventions

None listed

Sponsors

General Health Office, France
CollaboratorUNKNOWN
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* new prisoners * fluent French language

Exclusion criteria

* adult guardianship

Design outcomes

Primary

MeasureTime frameDescription
Description of the oral problems of people entering detention1 dayDescription of the oral problems of people entering detention : Any oral disease at inclusion (prevalence study)

Secondary

MeasureTime frameDescription
attending to consultationsThe collection of data will end at the discharge of the participant, or at 6 months after inclusion.attending to consultations : The rate of attended visits is defined as the number of visits attended by the patient, divided by the number of scheduled visits, during the prison stay of the participant.

Countries

France

Contacts

Primary ContactClaire M DUFLOS, MD
c-duflos@chu-montpellier.fr467336407

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026